An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Chronic Refractory Neuropathic Pain

Interventions

DRUG

Lacosamide

"Dosage: Lacosamide up to 400 mg/day;~Dosage form: Film-coated tablets;~Dosage Frequency and Duration: Two times per day; 9.5 years"

Trial Locations (1)

Monheim